Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
RFL Stock Forecast 2026-2027
$2.45
Current Price
$127.40M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to RFL Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
RFL Price Momentum
-22.2%
1 Week Change
+37.6%
1 Month Change
+14.0%
1 Year Change
+107.6%
Year-to-Date Change
-38.1%
From 52W High of $3.96
+118.8%
From 52W Low of $1.12
📊 TOP ANALYST CALLS
Did RFL Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Rafael Holdings is one of their latest high-conviction picks.
Latest RFL Stock Price Targets & Analyst Predictions
RFL has shown a year-to-date change of 107.6% and a 1-year change of 14.0%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for RFL. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
RFL Analyst Ratings
0
Buy
0
Hold
0
Sell
RFL Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $2.45
Latest RFL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for RFL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Rafael Holdings Inc. (RFL) Competitors
The following stocks are similar to Rafael Holdings based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Rafael Holdings Inc. (RFL) Financial Data
Rafael Holdings Inc. has a market capitalization of $127.40M with a P/E ratio of 14.3x. The company generates $980,000 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is -50.6% quarter-over-quarter, while maintaining an operating margin of -3,838.0% and return on equity of -37.6%.
Valuation Metrics
Market Cap
$127.40M
Enterprise Value
$119.05M
P/E Ratio
14.3x
PEG Ratio
-0.2x
Price/Sales
146.4x
Growth & Margins
Revenue Growth (YoY)
-50.6%
Gross Margin
+95.5%
Operating Margin
-3,838.0%
Net Margin
0.0%
EPS Growth
+132.5%
Financial Health
Cash/Price Ratio
+23.9%
Current Ratio
3.2x
Debt/Equity
0.8x
ROE
-37.6%
ROA
-22.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Rafael Holdings Inc. (RFL) Business Model
About Rafael Holdings Inc.
What They Do
Invests in healthcare and real estate ventures.
Business Model
Rafael Holdings operates as a holding company that invests in biopharmaceutical companies focused on cancer and metabolic disease therapies, while also managing a portfolio of commercial real estate properties. This diversified approach allows the company to generate revenue from stable real estate assets and potentially high-growth healthcare innovations.
Additional Information
The company primarily manages office buildings in Newark, New Jersey, and aims to bridge traditional real estate investment with biotech advancements. As a public entity, it provides investors with exposure to both physical property and innovative medical technologies, positioning itself as a contributor to healthcare solutions.
Company Information
Sector
Real Estate
Industry
Real Estate Services
Employees
21
CEO
Mr. Howard S. Jonas
Country
United States
IPO Year
2018
Website
www.rafaelholdings.comRafael Holdings Inc. (RFL) Latest News & Analysis
Latest News
Quick Summary
Rafael Holdings' Phase 3 trial of Trappsol Cyclo has finished, with results anticipated in H2 2026. The company has a 4-5 quarter runway and may need to borrow if delays occur.
Why It Matters
Rafael Holdings faces potential funding challenges if trial results are delayed, impacting financial health. Upcoming trial results will significantly influence stock performance and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Rafael Holdings, Inc. (NYSE: RFL) announced its financial results for Q3 of fiscal 2026, ending April 30, 2026. Further details on performance were not provided in the excerpt.
Why It Matters
Rafael Holdings' Q3 financial results can impact stock performance, affecting investor sentiment and potential market value based on revenue, profits, and growth indicators.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Rafael Holdings, Inc. (NYSE: RFL) announced the completion of the final study visit in its Phase 3 TransportNPC™ study for Trappsol® Cyclo™. NDA submission is expected in H2 2026.
Why It Matters
The upcoming NDA submission and positive FDA interactions could lead to a significant market opportunity for Rafael Holdings, impacting stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Rafael has secured a license for a MIT patent, enhancing its intellectual property on cyclodextrins as an Active Pharmaceutical Ingredient for treating ApoE4-positive Alzheimer's Disease.
Why It Matters
Rafael's strengthened patent on cyclodextrins for treating ApoE4-positive Alzheimer's enhances its market position and potential revenue, signaling growth opportunities for investors.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Rafael Holdings, Inc. (NYSE: RFL) announced its financial results for Q2 FY 2026, ending January 31, 2026. Further details on performance were not provided in the excerpt.
Why It Matters
Rafael Holdings' Q2 financial results can impact stock performance and investor sentiment, influencing trading strategies and valuations in the market.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Rafael Holdings, Inc. (NYSE: RFL) reported its financial results for Q1 FY 2026, ending October 31, 2025, on December 11, 2025. Further details on results were not provided in the excerpt.
Why It Matters
Rafael Holdings' Q1 fiscal 2026 financial results can significantly impact stock performance, influencing investor sentiment and potential valuations based on revenue and growth metrics.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About RFL Stock
What is Rafael Holdings Inc.'s (RFL) stock forecast for 2027?
Analyst forecasts for Rafael Holdings Inc. (RFL) are not currently available. The stock is trading at $2.45.
Is RFL stock a good investment in 2027?
Analyst ratings for RFL are not currently available. The stock is currently trading at $2.45. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for RFL stock?
Price predictions from Wall Street analysts for RFL are not currently available. The stock is trading at $2.45.
What is Rafael Holdings Inc.'s business model?
Rafael Holdings operates as a holding company that invests in biopharmaceutical companies focused on cancer and metabolic disease therapies, while also managing a portfolio of commercial real estate properties. This diversified approach allows the company to generate revenue from stable real estate assets and potentially high-growth healthcare innovations.
What is the highest forecasted price for RFL Rafael Holdings Inc.?
Price targets from Wall Street analysts for RFL are not currently available. The stock is trading at $2.45.
What is the lowest forecasted price for RFL Rafael Holdings Inc.?
Price targets from Wall Street analysts for RFL are not currently available. The stock is trading at $2.45.
What is the overall RFL consensus from analysts for Rafael Holdings Inc.?
Analyst ratings for RFL are not currently available. The stock is trading at $2.45.
How accurate are RFL stock price projections?
Stock price projections, including those for Rafael Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 9, 2026 11:04 AM UTC